Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients

NCT02874391 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT02874391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02874391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients
Lead sponsor
University Hospital, Angers
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2016
Completion date
September 30, 2019
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evaluate the risks of using arteriovenous fistula as first choise for drug administration